From: Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study
 | Single factor analysis | Multiple factor analysis | ||
---|---|---|---|---|
varium | HR (95% CI) | P | HR (95% CI) | P |
Age | 1.004 (1.001–1.007) | 0.008 | 1.003 (1.000–1.006) | 0.030 |
gender | 1.444 (0.938–2.221) | 0.095 | 0.723 (0.394–1.328) | 0.296 |
smoking | 2.293 (1.465–3.588) | 0.000 | 2.338 (1.236–4.424) | 0.009 |
Diabetes | 1.504 (0.651–3.474) | 0.339 |  |  |
Hemoglobin< 7.75 g/dl | 2.079 (1.358–3.182) | 0.001 | 1.362 (0.827–2.243) | 0.224 |
Albumin< 33.95 g/l | 1.902 (1.243–2.910) | 0.003 | 1.178 (0.740–1.874) | 0.490 |
baseline creatinine higher than 5.74 mg/dl | 3.190 (2.053–4.957) | 0.000 | 2.153 (1.323–3.502) | 0.002 |
CD4+T cell< 281/ul | 02.021 (1.316–3.105) | 0.001 | 1.813 (1.133–2.900) | 0.013 |
BVAS at the time of diagnosis > 25.5 | 1.883 (0.815–4.349) | 0.138 |  |  |
corticosteroids+MMF | 1.945 (1.156–3.272) | 0.012 | 1.004 (0.571–1.765) | 0.989 |
corticosteroids+CYC | 1.906 (1.073–3.383) | 0.028 | 1.951 (1.520–2.740) | 0.042 |
corticosteroids+TW | 1.519 (1.110–2.715) | 0.042 | 0.572 (0.262–1.250) | 0.161 |